A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Sponsor: Boehringer Ingelheim
Kansas City, KS · Wichita, KS · +86 more sites
13 recruiting heart failure studies with a site in Kansas City, KS.
Sponsor: Boehringer Ingelheim
Kansas City, KS · Wichita, KS · +86 more sites
Sponsor: Cytokinetics
Kansas City, KS · Overland Park, KS · +86 more sites
Sponsor: Reprieve Cardiovascular, Inc
Kansas City, KS · +34 more sites
Sponsor: Edwards Lifesciences
Kansas City, KS · +18 more sites
Sponsor: Medtronic Cardiovascular
Kansas City, KS · Wichita, KS · +69 more sites
Sponsor: Amgen
Kansas City, KS · Lenexa, KS · Wichita, KS · +118 more sites
Sponsor: Colorado Prevention Center
Kansas City, KS · +81 more sites
Sponsor: Duke University
Kansas City, KS · +49 more sites
Sponsor: Medtronic
Kansas City, KS · +112 more sites
Sponsor: Impulse Dynamics
Kansas City, KS · +27 more sites
Sponsor: International Consortium of Circulatory Assist Clinicians
Kansas City, KS · +6 more sites
Sponsor: University of Kansas Medical Center
Kansas City, KS · +11 more sites
Sponsor: P+F Products + Features USA Inc.
Kansas City, KS · +33 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.